Champions Oncology, Inc.SEC Filings
|
|
All SEC filings by Champions Oncology, Inc. (CSBR) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-K | Annual report | View Diff | Jul 27, 2026 | |
| 10-Q | Quarterly report | View Diff | Mar 12, 2026 | |
| 10-Q | Quarterly report | View Diff | Dec 15, 2025 | |
| 10-Q | Quarterly report | View Diff | Sep 15, 2025 | |
| 10-K | Annual report | View Diff | Jul 23, 2025 | |
| 10-Q | Quarterly report | View Diff | Mar 17, 2025 | |
| 10-Q | Quarterly report | View Diff | Dec 16, 2024 | |
| 10-Q | Quarterly report | View Diff | Sep 13, 2024 | |
| 10-K | Annual report | View Diff | Jul 19, 2024 | |
| 10-Q | Quarterly report | View Diff | Mar 14, 2024 |
Events
| 8-K | Champions Oncology Reports Record Annual Revenue of $59 Million | Jul 27, 2026 | ||
| 8-K | Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy | Mar 30, 2026 | ||
| 8-K | Champions Oncology Reports Revenue of $16.6 Million | Mar 12, 2026 | ||
| 8-K | Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million | Dec 15, 2025 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | Oct 16, 2025 | ||
| 8-K | Champions Oncology Reports Quarterly Revenue of $14.0 Million | Sep 15, 2025 | ||
| 8-K | Champions Oncology Reports Record Annual Revenue of $57 Million | Jul 23, 2025 | ||
| 8-K | Champions Oncology Announces Appointment of New Ceo | Jul 21, 2025 | ||
| 8-K | Champions Oncology Reports Record Quarterly Revenue of $17.0 Million | Mar 11, 2025 | ||
| 8-K | Champions Oncology Reports Quarterly Revenue of $13.5 Million | Dec 11, 2024 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Oct 30, 2024 | ||
| 424B4 | Prospectus supplement with pricing info | Jun 10, 2016 | ||
| S-1/A | IPO registration | View Diff | May 24, 2016 | |
| S-1 | IPO registration | View Diff | Apr 26, 2016 | |
| 424B3 | Prospectus supplement | Oct 15, 2015 | ||
| POS AM | Prospectus update (post-effective amendment) | Sep 25, 2015 | ||
| 8-A12B | Registration of securities on exchange | Aug 20, 2015 | ||
| 424B3 | Prospectus supplement | May 19, 2015 | ||
| S-1 | IPO registration | May 11, 2015 | ||
| D | $14m in Equity / Options, Sold $14m, 11 Investors | Mar 25, 2015 |
Proxies
| DEFA14A | Annual Meeting of Shareholders | Aug 28, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Aug 28, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Aug 22, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Aug 22, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Aug 27, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Aug 27, 2024 | |
| DEFA14A | Additional proxy soliciting materials | Aug 28, 2023 | ||
| DEF 14A | Definitive proxy | View Diff | Aug 28, 2023 | |
| DEF 14A | Definitive proxy | View Diff | Aug 31, 2022 | |
| DEF 14A | Definitive proxy | View Diff | Aug 29, 2022 |
Other
| UPLOAD | Letter from SEC | Mar 4, 2025 | ||
| CORRESP | Correspondence with SEC | Mar 3, 2025 | ||
| UPLOAD | Letter from SEC | Feb 26, 2025 | ||
| EFFECT | Notice of effectiveness | Jun 9, 2016 | ||
| CORRESP | Correspondence with SEC | Jun 8, 2016 | ||
| CORRESP | Correspondence with SEC | Jun 8, 2016 | ||
| CORRESP | Correspondence with SEC | May 23, 2016 | ||
| UPLOAD | Letter from SEC | May 5, 2016 | ||
| EFFECT | Notice of effectiveness | Oct 13, 2015 | ||
| EFFECT | Notice of effectiveness | May 19, 2015 |
Ownership
| 4 | Robert Lawrence Brainin | Jan 30, 2026 | ||
| 4 | Robert Lawrence Brainin | Jan 30, 2026 | ||
| 3 | Robert Lawrence Brainin | Jan 16, 2026 | ||
| 4 | Philip P. Breitfeld | Nov 7, 2025 | ||
| 4 | David Sidransky | Nov 7, 2025 | ||
| 4 | Daniel Newman Mendelson | Nov 7, 2025 | ||
| 4 | Scott R Tobin | Nov 7, 2025 | ||
| 4 | Joel Ackerman | Nov 7, 2025 | ||
| 4 | Joel Ackerman | Nov 6, 2025 | ||
| 4 | Philip P. Breitfeld | Apr 2, 2025 |